210 related articles for article (PubMed ID: 27917627)
21. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses.
Lawrence TM; Wanjalla CN; Gomme EA; Wirblich C; Gatt A; Carnero E; García-Sastre A; Lyles DS; McGettigan JP; Schnell MJ
PLoS One; 2013; 8(6):e67123. PubMed ID: 23840600
[TBL] [Abstract][Full Text] [Related]
22. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
[TBL] [Abstract][Full Text] [Related]
23. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the expression and immunogenicity of wild-type and sequence-modified HIV-1 gag genes in a recombinant Sendai virus vector.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Li H; Li Z; Zhong R; Zeng Y
Curr HIV Res; 2010 Apr; 8(3):199-206. PubMed ID: 20158459
[TBL] [Abstract][Full Text] [Related]
25. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants.
Jiang Y; Li M; Zhang Z; Gong T; Sun X
Pharm Res; 2014 Oct; 31(10):2748-61. PubMed ID: 24792827
[TBL] [Abstract][Full Text] [Related]
28. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
[TBL] [Abstract][Full Text] [Related]
29. Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice.
Chin'ombe N; Bourn WR; Williamson AL; Shephard EG
Virol J; 2009 Jun; 6():87. PubMed ID: 19555490
[TBL] [Abstract][Full Text] [Related]
30. A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV).
Shen YJ; Shephard E; Douglass N; Johnston N; Adams C; Williamson C; Williamson AL
Virol J; 2011 May; 8():265. PubMed ID: 21624130
[TBL] [Abstract][Full Text] [Related]
31. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
32. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
33. DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.
Chikhlikar P; Barros de Arruda L; Maciel M; Silvera P; Lewis MG; August JT; Marques ET
PLoS One; 2006 Dec; 1(1):e135. PubMed ID: 17205139
[TBL] [Abstract][Full Text] [Related]
34. Boosting Tat DNA vaccine with Tat protein stimulates strong cellular and humoral immune responses in mice.
Alipour S; Mahdavi A
Biotechnol Lett; 2020 Apr; 42(4):505-517. PubMed ID: 31974645
[TBL] [Abstract][Full Text] [Related]
35. Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.
Ko SY; Cheng C; Kong WP; Wang L; Kanekiyo M; Einfeld D; King CR; Gall JG; Nabel GJ
J Virol; 2009 Jan; 83(2):748-56. PubMed ID: 18987146
[TBL] [Abstract][Full Text] [Related]
36. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
37. Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity.
Asefa B; Korokhov N; Lemiale F
Vaccine; 2010 Apr; 28(20):3617-24. PubMed ID: 20051277
[TBL] [Abstract][Full Text] [Related]
38. A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
Meador LR; Kessans SA; Kilbourne J; Kibler KV; Pantaleo G; Roderiguez ME; Blattman JN; Jacobs BL; Mor TS
Virology; 2017 Jul; 507():242-256. PubMed ID: 28458036
[TBL] [Abstract][Full Text] [Related]
39. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
[TBL] [Abstract][Full Text] [Related]
40. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.
Koup RA; Roederer M; Lamoreaux L; Fischer J; Novik L; Nason MC; Larkin BD; Enama ME; Ledgerwood JE; Bailer RT; Mascola JR; Nabel GJ; Graham BS; ;
PLoS One; 2010 Feb; 5(2):e9015. PubMed ID: 20126394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
